| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Property, plant and equipment | 0 | - |
| Net cash used in investing activities | 0 | - |
| Issuance of shares for services | 0 | - |
| Net loss | -1,362,890 | -671,977 |
| Stock based compensation | 11,936 | 5,935 |
| Accretion and amortization expenses | -355,713 | -153,572 |
| Change in fair value of derivative liabilities | -33,971 | -25,200 |
| Loss (gain) on debt conversion and redemption | -8,433 | -8,433 |
| Non cash lease expense | 225,373 | 110,870 |
| Accounts receivable, net | 453,519 | 205,418 |
| Issuance of shares for services | - | 0 |
| Inventory | 700,904 | 228,041 |
| Deposits and other receivables | -187,570 | 49,117 |
| Advance from customers | 1,895,920 | - |
| Accounts payable and accrued liabilities | -145,473 | 492,532 |
| Property, plant and equipment depreciation | 2,977 | 1,488 |
| Net cash generated (used) in operating activities | 42,241 | -373,389 |
| Issuance of common shares, net | 0 | 0 |
| Proceeds from (repayment to) convertible debentures, net | 0 | - |
| Issuance of preferred shares, net | 0 | 0 |
| Proceeds from (repayment to) short term loan and promissory notes, net | 739,990 | 441,623 |
| Term loan, net | 600,000 | - |
| Preferred stock dividend | 12,033 | 5,918 |
| Redemption of preferred shares | 200,000 | - |
| Net cash provided (used) in financing activities | -72,043 | 435,705 |
| Net increase (decrease) in cash during the period | -29,802 | 62,316 |
| Effect of exchange rate changes on cash | -26,883 | - |
| Cash and cash equivalents at beginning of period | 365,145 | - |
| Cash and cash equivalents at end of period | 308,460 | - |
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)